SCHEMBL4316197

SCHEMBL4316197

c1cc(-c2c3ccccc3c(-c3cccc(-c4cc5ccccc5c5ccccc45)c3)c3ccccc23)cc(-c2cc3ccccc3c3ccccc23)c1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP11B1 P15538 1/20 0.53
▸ ALDH1A1 P00352 4/20 0.47
▸ HSD17B10 Q99714 3/20 0.47
▸ HPGD P15428 2/20 0.47
▸ HIF1A Q16665 2/20 0.47
▸ TSHR P16473 2/20 0.47
▸ MAPK1 P28482 1/20 0.47
▸ CASP1 P29466 1/20 0.47
▸ L3MBTL1 Q9Y468 1/20 0.47
▸ MEN1 O00255 3/20 0.44
▸ KMT2A Q03164 3/20 0.44
▸ KDM4E B2RXH2 2/20 0.44
▸ MAPT P10636 1/20 0.44
▸ MPI P34949 1/20 0.44
▸ ALOX5 P09917 3/20 0.43
▸ TRPM4 Q8TD43 1/20 0.42
▸ CYP1B1 Q16678 1/20 0.41
▸ GPR84 Q9NQS5 3/20 0.40
▸ HPRT1 P00492 1/20 0.39
▸ NISCH Q9Y2I1 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31690682 0.96 CYP11B1 (0.50) CYP11B1ALDH1A1HSD17B10HPGDHIF1A
SCHEMBL18631543 0.91 CYP11B1 (0.46) CYP11B1ALDH1A1HSD17B10HPGDHIF1A
SCHEMBL12520786 0.90 CYP11B1 (0.58) CYP11B1ALDH1A1HSD17B10HPGDHIF1A
SCHEMBL24618934 0.88 GPR84 (0.47) CYP11B1ALDH1A1HSD17B10HPGDHIF1A
SCHEMBL13016388 0.88 CYP11B1 (0.46) CYP11B1ALDH1A1HSD17B10HPGDHIF1A
SCHEMBL22978404 0.88 ALDH1A1 (0.44) CYP11B1ALDH1A1HSD17B10HPGDHIF1A
SCHEMBL30350883 0.88 ALDH1A1 (0.44) CYP11B1ALDH1A1HSD17B10HPGDHIF1A
SCHEMBL13991446 0.87 CYP11B1 (0.46) CYP11B1ALDH1A1HSD17B10HPGDHIF1A
SCHEMBL24173970 0.87 CYP11B1 (0.45) CYP11B1ALDH1A1HSD17B10HPGDHIF1A
SCHEMBL29006475 0.86 CYP11B1 (0.55) CYP11B1ALDH1A1HSD17B10HPGDHIF1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7504163-B2 Hole-trapping materials for improved OLED efficiency EASTMAN KODAK COMPANY (US) 2009-03-17 — — US disclosed
US-20080193799-A1 Organic electroluminescence device IDEMITSU KOSAN CO., LTD. (JP) 2008-08-14 — — US disclosed
US-7361796-B2 Orangic electroluminescence device IDEMITSU KOSAN CO., LTD. (JP) 2008-04-22 — — US disclosed
US-20070126347-A1 OLEDS with improved efficiency EASTMAN KODAK COMPANY 2007-06-07 — — US disclosed
US-7053255-B2 Substituted diphenylanthracene compounds for organic electroluminescence devices IDEMITSU KOSAN CO., LTD. (JP) 2006-05-30 — — US disclosed
US-20060083947-A1 Organic electroluminescence device IDEMITSU KOSAN CO., LTD. (JP) 2006-04-20 — — US disclosed
US-20060008672-A1 Hole-trapping materials for improved OLED efficiency EASTMAN KODAK COMPANY 2006-01-12 — — US disclosed
US-20040214035-A1 Organic electroluminescence device IDEMITSU KOSAN CO., LTD. 2004-10-28 — — US disclosed
EP-1333018-A1 ORGANIC ELECTROLUMINESCENT ELEMENT IDEMITSU KOSAN CO., LTD. (JP) 2003-08-06 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080193799-A1 Organic electroluminescence device EED, KCNH2, DCX CYP11B1 2698/4885ALDH1A1 66/4885HSD17B10 1570/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback